Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines
US7202245B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2004 |
| Grant date | Apr 10, 2007 |
| Priority date | — |
| Expiry date | Dec 24, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I)the prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein Ra, Rb, R1, and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.